COX-2 inhibition as a tool to treat and prevent colorectal cancer
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 52 (2) , 81-101
Abstract
No abstract availableKeywords
This publication has 197 references indexed in Scilit:
- Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survivalCancer, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling PathwaysBiochemical and Biophysical Research Communications, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzymeBiochemical and Biophysical Research Communications, 1989